| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042759172 |
| P356 | DOI | 10.1007/S10549-008-0295-8 |
| P698 | PubMed publication ID | 19189211 |
| P50 | author | Steven A. Narod | Q50384888 |
| P2093 | author name string | Ping Sun | |
| Wedad M Hanna | |||
| Maureen Trudeau | |||
| Ellen Rawlinson | |||
| Harriet K Kahn | |||
| Rebecca Dent | |||
| Sharon Nofech-Mozes | |||
| P2860 | cites work | Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome | Q24684801 |
| Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors | Q40181736 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 131-137 | |
| P577 | publication date | 2009-02-03 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers | |
| P478 | volume | 118 |
| Q36432567 | A DNA repair BRCA1 estrogen receptor and targeted therapy in breast cancer |
| Q34209378 | A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease |
| Q42492946 | A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments |
| Q37782088 | Beyond triple-negative breast cancer: the need to define new subtypes |
| Q91987366 | CLCA2 expression is associated with survival among African American women with triple negative breast cancer |
| Q34334159 | Cancer progression modeling using static sample data |
| Q34479003 | Characteristics of triple-negative breast cancer |
| Q47652073 | Circulating tumour cells in non-metastatic breast cancer: a prospective study |
| Q33751806 | Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis |
| Q64242147 | DNA Ligase IV Prevents Replication Fork Stalling and Promotes Cellular Proliferation in Triple Negative Breast Cancer |
| Q36001170 | Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients |
| Q61446661 | Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC |
| Q95644301 | EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer |
| Q36846498 | Genetic susceptibility to triple-negative breast cancer |
| Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
| Q27015775 | Genomic profiling in triple-negative breast cancer |
| Q36095938 | Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy. |
| Q42478594 | Intratumoral Expression Level of Epidermal Growth Factor Receptor and Cytokeratin 5/6 Is Significantly Associated With Nodal and Distant Metastases in Patients With Basal-like Triple-Negative Breast Carcinoma |
| Q36166242 | Invasive lobular carcinoma predicts micrometastasis in breast cancer |
| Q38131416 | Is there a correlation between breast cancer molecular subtype using receptors as surrogates and mammographic appearance? |
| Q33758934 | Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study |
| Q34585874 | MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells |
| Q48263230 | MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1. |
| Q21261291 | Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool? |
| Q36343773 | Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy |
| Q34038395 | PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis |
| Q37690172 | Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index. |
| Q37551110 | Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers |
| Q42506718 | Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer |
| Q83640557 | Significance of histomorphology of early triple-negative breast cancer |
| Q33726477 | Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells |
| Q90102543 | Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells |
| Q34096063 | The Role of Targeted Agents in the Treatment of Metastatic Breast Cancer. |
| Q37958063 | The paradox of triple negative breast cancer: novel approaches to treatment |
| Q37931893 | Therapeutic potential of PARP inhibitors for metastatic breast cancer |
| Q42458660 | Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status |
| Q38940118 | Triple Negative Breast Cancer at the University Hospital Mohammed VI – Oujda |
| Q42491445 | Triple negative and basal-like breast cancer in East Africa |
| Q36024205 | Triple negative breast cancer - our experience and review |
| Q35630269 | Triple negative breast cancer: unmet medical needs |
| Q35111687 | Triple-negative breast cancer is not a contraindication for breast conservation |
| Q37630082 | Triple-negative breast cancer--current status and future directions |
| Q35692146 | Triple-negative breast cancer: adjuvant therapeutic options |
| Q37809844 | Triple-negative breast cancer: epidemiology and management options |
| Q28077243 | Triple-negative breast cancer: is there a treatment on the horizon? |
| Q38004606 | Triple-negative breast cancer: making the most of a misnomer |
| Q37687380 | Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features |
Search more.